Clinical Trial Update: Enhancing Effect on Tumour Apoptosis With the Use of Pentoxifylline in Patients With Hodgkin Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating pentoxifylline to enhance tumor cell death in Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: University of Guadalajara | Conditions: Hodgkin Lymphoma | Phase 4 | Status: UNKNOWN